EDGAR Filing Documents for 0000898432-07-000102

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000898432-07-000102

Filing Date

2007-02-05

Accepted

2007-02-05 14:28:56

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1		bvf-targacept_sc13g.htm	SC 13G	102359
2	EXHIBIT 1	exhibit_99.htm	EX-99	12944
	Complete submission text file	0000898432-07-000102.txt		117538

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606

Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101

Business Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101 3364802100

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 07579786
SIC: 2834 Pharmaceutical Preparations